TINAVI Medical Technologies Co., Ltd. (688277.SS)
CNY 10.83
(-0.46%)
CNY 10.83
(-0.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 210.03 Million | 156.18 Million | 156.02 Million | 135.9 Million | 229.56 Million | 126.72 Million |
| Cost of Revenue | 60.61 Million | 53.63 Million | 49.95 Million | 31.26 Million | 34.55 Million | 30.25 Million |
| Gross Profit | 149.42 Million | 102.55 Million | 106.07 Million | 104.64 Million | 195 Million | 96.46 Million |
| Operating Expenses | 299.82 Million | 248.91 Million | 209.58 Million | 175.84 Million | 239.79 Million | 86.44 Million |
| Selling, General and Administrative Expenses | 174.01 Million | 112.6 Million | 83.86 Million | 89.34 Million | 128.16 Million | 56.79 Million |
| Research and Development Expenses | 140.31 Million | 122.63 Million | 109.79 Million | 74.11 Million | 77.01 Million | 41.48 Million |
| Other Expenses | 2.19 Million | 13.67 Million | 15.92 Million | 12.38 Million | 34.62 Million | 98.68 Thousand |
| Cost and Expenses | 360.43 Million | 302.55 Million | 259.53 Million | 207.11 Million | 274.35 Million | 116.7 Million |
| Operating Income | -149.42 Million | -146.36 Million | -103.51 Million | -71.2 Million | -44.78 Million | -8.09 Million |
| Interest Expense | 6.42 Million | 3.94 Million | 3.34 Million | 62.54 Thousand | 71.62 Thousand | 162.63 Thousand |
| Income Tax Expense | 10.6 Million | -31.82 Million | -22 Million | -14.23 Million | -8.67 Million | -4.33 Million |
| Earnings before Tax | -149.74 Million | -144.15 Million | -104.65 Million | -68.39 Million | -42.84 Million | -7.99 Million |
| Net Income | -156.38 Million | -112.33 Million | -82.65 Million | -54.16 Million | -34.16 Million | -855.97 Thousand |
| Earnings Per Share Basic | -0.35 | -0.27 | -0.20 | -0.13 | -0.08 | -0.00 |
| Earnings Per Share Diluted | -0.35 | -0.27 | -0.20 | -0.13 | -0.08 | -0.00 |
| Weighted Average Shares Outstanding | 446.81 Million | 419.84 Million | 419.84 Million | 418.44 Million | 418.44 Million | 309.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 446.81 Million | 419.84 Million | 419.84 Million | 418.44 Million | 418.44 Million | 309.56 Million |
| Gross Margin | 0.71 | 0.66 | 0.68 | 0.77 | 0.85 | 0.76 |
| EBIT Margin | -0.49 | -0.63 | -0.39 | -0.45 | -0.15 | 0.16 |
| Profit Margin | -0.74 | -0.72 | -0.53 | -0.40 | -0.15 | -0.01 |
| EBITDA | -102.67 Million | -87.15 Million | -59.64 Million | -51.46 Million | -27.49 Million | -1.72 Million |
| Earnings Before Tax Margin | -0.71 | -0.94 | -0.66 | -0.52 | -0.20 | -0.06 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 32.12 Million | 29.36 Million | 28.12 Million | 209.93 Million | 76.27 Million | 51.75 Million |
| Cost of Revenue | 11.8 Million | 7.5 Million | 10.67 Million | 60.61 Million | 18.93 Million | 13.53 Million |
| Gross Profit | 20.32 Million | 21.86 Million | 17.44 Million | 149.32 Million | 57.33 Million | 38.21 Million |
| Operating Expenses | 58.11 Million | 63.56 Million | 66.97 Million | 359.36 Million | 126.57 Million | 78.49 Million |
| Selling, General and Administrative Expenses | 35.35 Million | 23.77 Million | 40.88 Million | - | 21.85 Million | 75.29 Million |
| Research and Development Expenses | 22.99 Million | 21.76 Million | 25.89 Million | - | 53.75 Million | 27.69 Million |
| Other Expenses | 235.04 Thousand | -1.52 Million | -196.9 Thousand | -359.36 Million | -126.57 Million | 20 Thousand |
| Cost and Expenses | 69.92 Million | 71.06 Million | 77.65 Million | 359.36 Million | 126.57 Million | 92.03 Million |
| Operating Income | -37.79 Million | -43.26 Million | -49.52 Million | -149.42 Million | -50.3 Million | -44.85 Million |
| Interest Expense | 2.34 Million | 2.45 Million | 2.31 Million | 6.42 Million | 2.61 Million | 2.1 Million |
| Income Tax Expense | -7.92 Million | -6.87 Million | -5.72 Million | 11.18 Million | 33.33 Million | -9.65 Million |
| Earnings before Tax | -36.9 Million | -43.29 Million | -14.35 Million | -149.74 Million | -50.59 Million | -44.83 Million |
| Net Income | -29.68 Million | -36.42 Million | -10.06 Million | -160.93 Million | -83.93 Million | -35.18 Million |
| Earnings Per Share Basic | -0.07 | -0.08 | -0.02 | - | -0.19 | -0.08 |
| Earnings Per Share Diluted | -0.07 | -0.08 | -0.02 | - | -0.19 | -0.08 |
| Weighted Average Shares Outstanding | 449.39 Million | 449.39 Million | 449.39 Million | 446.81 Million | 435.75 Million | 449.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 449.39 Million | 449.39 Million | 449.39 Million | 446.81 Million | 435.75 Million | 449.39 Million |
| Gross Margin | 0.63 | 0.74 | 0.62 | 0.71 | 0.75 | 0.74 |
| EBIT Margin | -1.08 | -1.40 | -0.46 | - | -0.60 | -0.82 |
| Profit Margin | -0.92 | -1.24 | -0.36 | -0.77 | -1.10 | -0.68 |
| EBITDA | -34.56 Million | -41.12 Million | -12.92 Million | - | -45.95 Million | -42.45 Million |
| Earnings Before Tax Margin | -1.18 | -1.47 | -1.76 | -0.71 | -0.66 | -0.87 |
TBLMF
BICTF
1910
KEJU
GRE
2881